AMA submission to the TGA on updated therapeutic goods advertising code and guidelines

The AMA supports, in principle, the changes proposed to the therapeutic goods advertising code because they will strengthen and clarify the advertising of therapeutic goods in a modern media environment. However, the draft guidelines circulated for public comment are incomplete in significant areas. The AMA also continues to oppose the default advertising of Schedule 3 medicines, especially given the intention to move to industry self-regulation.